nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—PGR—Betamethasone—ankylosing spondylitis	0.138	0.148	CbGbCtD
Mifepristone—NR3C1—Methylprednisolone—ankylosing spondylitis	0.109	0.116	CbGbCtD
Mifepristone—NR3C1—Triamcinolone—ankylosing spondylitis	0.0823	0.0883	CbGbCtD
Mifepristone—PGR—Dexamethasone—ankylosing spondylitis	0.0804	0.0862	CbGbCtD
Mifepristone—NR3C1—Betamethasone—ankylosing spondylitis	0.0706	0.0757	CbGbCtD
Mifepristone—NR3C1—Prednisolone—ankylosing spondylitis	0.0697	0.0747	CbGbCtD
Mifepristone—NR3C1—Prednisone—ankylosing spondylitis	0.0658	0.0706	CbGbCtD
Mifepristone—NR3C1—Dexamethasone—ankylosing spondylitis	0.0411	0.0441	CbGbCtD
Mifepristone—ABCC1—Methotrexate—ankylosing spondylitis	0.0319	0.0342	CbGbCtD
Mifepristone—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0294	0.0316	CbGbCtD
Mifepristone—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0253	0.0271	CbGbCtD
Mifepristone—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0196	0.021	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0196	0.021	CbGbCtD
Mifepristone—ABCB1—Betamethasone—ankylosing spondylitis	0.0164	0.0176	CbGbCtD
Mifepristone—ABCB1—Prednisolone—ankylosing spondylitis	0.0162	0.0174	CbGbCtD
Mifepristone—ABCB1—Prednisone—ankylosing spondylitis	0.0153	0.0164	CbGbCtD
Mifepristone—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0152	0.0163	CbGbCtD
Mifepristone—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0147	0.0158	CbGbCtD
Mifepristone—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0115	0.0123	CbGbCtD
Mifepristone—CYP3A4—Betamethasone—ankylosing spondylitis	0.00985	0.0106	CbGbCtD
Mifepristone—CYP3A4—Prednisolone—ankylosing spondylitis	0.00972	0.0104	CbGbCtD
Mifepristone—ABCB1—Dexamethasone—ankylosing spondylitis	0.00956	0.0103	CbGbCtD
Mifepristone—CYP3A4—Prednisone—ankylosing spondylitis	0.00918	0.00985	CbGbCtD
Mifepristone—CYP2D6—Dexamethasone—ankylosing spondylitis	0.00901	0.00967	CbGbCtD
Mifepristone—ABCB1—Methotrexate—ankylosing spondylitis	0.00769	0.00824	CbGbCtD
Mifepristone—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00573	0.00615	CbGbCtD
Mifepristone—Muscular weakness—Methylprednisolone—ankylosing spondylitis	0.000399	0.00589	CcSEcCtD
Mifepristone—Hypokalaemia—Dexamethasone—ankylosing spondylitis	0.000374	0.00553	CcSEcCtD
Mifepristone—Hypokalaemia—Betamethasone—ankylosing spondylitis	0.000374	0.00553	CcSEcCtD
Mifepristone—Muscular weakness—Dexamethasone—ankylosing spondylitis	0.000363	0.00536	CcSEcCtD
Mifepristone—Muscular weakness—Betamethasone—ankylosing spondylitis	0.000363	0.00536	CcSEcCtD
Mifepristone—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.000348	0.00515	CcSEcCtD
Mifepristone—Infestation—Methylprednisolone—ankylosing spondylitis	0.000348	0.00515	CcSEcCtD
Mifepristone—Haemoglobin—Prednisolone—ankylosing spondylitis	0.000343	0.00506	CcSEcCtD
Mifepristone—Haemorrhage—Prednisolone—ankylosing spondylitis	0.000341	0.00504	CcSEcCtD
Mifepristone—Hypokalaemia—Prednisone—ankylosing spondylitis	0.000326	0.00482	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.000317	0.00469	CcSEcCtD
Mifepristone—Muscular weakness—Prednisone—ankylosing spondylitis	0.000316	0.00467	CcSEcCtD
Mifepristone—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.000315	0.00466	CcSEcCtD
Mifepristone—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.000314	0.00465	CcSEcCtD
Mifepristone—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.000314	0.00463	CcSEcCtD
Mifepristone—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.000313	0.00462	CcSEcCtD
Mifepristone—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000307	0.00454	CcSEcCtD
Mifepristone—Haemoglobin—Betamethasone—ankylosing spondylitis	0.000286	0.00422	CcSEcCtD
Mifepristone—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.000286	0.00422	CcSEcCtD
Mifepristone—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000284	0.0042	CcSEcCtD
Mifepristone—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000284	0.0042	CcSEcCtD
Mifepristone—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000284	0.00419	CcSEcCtD
Mifepristone—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000282	0.00417	CcSEcCtD
Mifepristone—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000275	0.00407	CcSEcCtD
Mifepristone—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000274	0.00405	CcSEcCtD
Mifepristone—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000272	0.00402	CcSEcCtD
Mifepristone—Angioedema—Prednisolone—ankylosing spondylitis	0.000271	0.00401	CcSEcCtD
Mifepristone—Breast disorder—Methotrexate—ankylosing spondylitis	0.00027	0.004	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000269	0.00398	CcSEcCtD
Mifepristone—Malaise—Prednisolone—ankylosing spondylitis	0.000268	0.00395	CcSEcCtD
Mifepristone—Back pain—Triamcinolone—ankylosing spondylitis	0.000264	0.0039	CcSEcCtD
Mifepristone—Angiopathy—Betamethasone—ankylosing spondylitis	0.000258	0.00381	CcSEcCtD
Mifepristone—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000258	0.00381	CcSEcCtD
Mifepristone—Hypertension—Prednisolone—ankylosing spondylitis	0.000256	0.00379	CcSEcCtD
Mifepristone—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000253	0.00374	CcSEcCtD
Mifepristone—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000253	0.00373	CcSEcCtD
Mifepristone—Discomfort—Prednisolone—ankylosing spondylitis	0.00025	0.00369	CcSEcCtD
Mifepristone—Angioedema—Triamcinolone—ankylosing spondylitis	0.000249	0.00368	CcSEcCtD
Mifepristone—Haemoglobin—Prednisone—ankylosing spondylitis	0.000249	0.00368	CcSEcCtD
Mifepristone—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000249	0.00368	CcSEcCtD
Mifepristone—Haemorrhage—Prednisone—ankylosing spondylitis	0.000248	0.00366	CcSEcCtD
Mifepristone—Malaise—Triamcinolone—ankylosing spondylitis	0.000246	0.00364	CcSEcCtD
Mifepristone—Malaise—Methylprednisolone—ankylosing spondylitis	0.000246	0.00363	CcSEcCtD
Mifepristone—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000243	0.0036	CcSEcCtD
Mifepristone—Oedema—Prednisolone—ankylosing spondylitis	0.000242	0.00358	CcSEcCtD
Mifepristone—Hypertension—Triamcinolone—ankylosing spondylitis	0.000236	0.00348	CcSEcCtD
Mifepristone—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000235	0.00347	CcSEcCtD
Mifepristone—Myalgia—Triamcinolone—ankylosing spondylitis	0.000232	0.00343	CcSEcCtD
Mifepristone—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000232	0.00343	CcSEcCtD
Mifepristone—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000232	0.00343	CcSEcCtD
Mifepristone—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000231	0.00341	CcSEcCtD
Mifepristone—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000231	0.00341	CcSEcCtD
Mifepristone—Infestation—Methotrexate—ankylosing spondylitis	0.000231	0.00341	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00023	0.0034	CcSEcCtD
Mifepristone—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00023	0.00339	CcSEcCtD
Mifepristone—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00023	0.00339	CcSEcCtD
Mifepristone—Discomfort—Triamcinolone—ankylosing spondylitis	0.00023	0.00339	CcSEcCtD
Mifepristone—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000229	0.00338	CcSEcCtD
Mifepristone—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000227	0.00336	CcSEcCtD
Mifepristone—Angioedema—Betamethasone—ankylosing spondylitis	0.000226	0.00334	CcSEcCtD
Mifepristone—Angioedema—Dexamethasone—ankylosing spondylitis	0.000226	0.00334	CcSEcCtD
Mifepristone—Angiopathy—Prednisone—ankylosing spondylitis	0.000225	0.00332	CcSEcCtD
Mifepristone—Malaise—Betamethasone—ankylosing spondylitis	0.000223	0.0033	CcSEcCtD
Mifepristone—Malaise—Dexamethasone—ankylosing spondylitis	0.000223	0.0033	CcSEcCtD
Mifepristone—Oedema—Triamcinolone—ankylosing spondylitis	0.000223	0.00329	CcSEcCtD
Mifepristone—Infection—Triamcinolone—ankylosing spondylitis	0.000221	0.00327	CcSEcCtD
Mifepristone—Infection—Methylprednisolone—ankylosing spondylitis	0.000221	0.00326	CcSEcCtD
Mifepristone—Insomnia—Prednisolone—ankylosing spondylitis	0.000219	0.00324	CcSEcCtD
Mifepristone—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000218	0.00322	CcSEcCtD
Mifepristone—Mental disorder—Prednisone—ankylosing spondylitis	0.000217	0.00321	CcSEcCtD
Mifepristone—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000216	0.00319	CcSEcCtD
Mifepristone—Malnutrition—Prednisone—ankylosing spondylitis	0.000216	0.00319	CcSEcCtD
Mifepristone—Hypertension—Dexamethasone—ankylosing spondylitis	0.000214	0.00316	CcSEcCtD
Mifepristone—Hypertension—Betamethasone—ankylosing spondylitis	0.000214	0.00316	CcSEcCtD
Mifepristone—Myalgia—Dexamethasone—ankylosing spondylitis	0.000211	0.00311	CcSEcCtD
Mifepristone—Myalgia—Betamethasone—ankylosing spondylitis	0.000211	0.00311	CcSEcCtD
Mifepristone—Anxiety—Betamethasone—ankylosing spondylitis	0.00021	0.0031	CcSEcCtD
Mifepristone—Anxiety—Dexamethasone—ankylosing spondylitis	0.00021	0.0031	CcSEcCtD
Mifepristone—Discomfort—Betamethasone—ankylosing spondylitis	0.000208	0.00308	CcSEcCtD
Mifepristone—Discomfort—Dexamethasone—ankylosing spondylitis	0.000208	0.00308	CcSEcCtD
Mifepristone—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000208	0.00307	CcSEcCtD
Mifepristone—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000208	0.00307	CcSEcCtD
Mifepristone—Pain—Prednisolone—ankylosing spondylitis	0.000207	0.00306	CcSEcCtD
Mifepristone—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000207	0.00306	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000203	0.003	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000202	0.00299	CcSEcCtD
Mifepristone—Oedema—Dexamethasone—ankylosing spondylitis	0.000202	0.00299	CcSEcCtD
Mifepristone—Oedema—Betamethasone—ankylosing spondylitis	0.000202	0.00299	CcSEcCtD
Mifepristone—Insomnia—Triamcinolone—ankylosing spondylitis	0.000201	0.00298	CcSEcCtD
Mifepristone—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000201	0.00297	CcSEcCtD
Mifepristone—Infection—Betamethasone—ankylosing spondylitis	0.000201	0.00297	CcSEcCtD
Mifepristone—Infection—Dexamethasone—ankylosing spondylitis	0.000201	0.00297	CcSEcCtD
Mifepristone—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.0002	0.00296	CcSEcCtD
Mifepristone—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.0002	0.00295	CcSEcCtD
Mifepristone—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000199	0.00293	CcSEcCtD
Mifepristone—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000198	0.00293	CcSEcCtD
Mifepristone—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000198	0.00293	CcSEcCtD
Mifepristone—Angioedema—Prednisone—ankylosing spondylitis	0.000197	0.00291	CcSEcCtD
Mifepristone—Malaise—Prednisone—ankylosing spondylitis	0.000194	0.00287	CcSEcCtD
Mifepristone—Anorexia—Dexamethasone—ankylosing spondylitis	0.000193	0.00285	CcSEcCtD
Mifepristone—Anorexia—Betamethasone—ankylosing spondylitis	0.000193	0.00285	CcSEcCtD
Mifepristone—Urticaria—Prednisolone—ankylosing spondylitis	0.000192	0.00284	CcSEcCtD
Mifepristone—Fatigue—Triamcinolone—ankylosing spondylitis	0.000192	0.00284	CcSEcCtD
Mifepristone—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000192	0.00283	CcSEcCtD
Mifepristone—Pain—Triamcinolone—ankylosing spondylitis	0.00019	0.00281	CcSEcCtD
Mifepristone—Hypotension—Betamethasone—ankylosing spondylitis	0.000189	0.00279	CcSEcCtD
Mifepristone—Hypotension—Dexamethasone—ankylosing spondylitis	0.000189	0.00279	CcSEcCtD
Mifepristone—Angiopathy—Methotrexate—ankylosing spondylitis	0.000188	0.00278	CcSEcCtD
Mifepristone—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000187	0.00276	CcSEcCtD
Mifepristone—Hypertension—Prednisone—ankylosing spondylitis	0.000186	0.00275	CcSEcCtD
Mifepristone—Chills—Methotrexate—ankylosing spondylitis	0.000186	0.00274	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000184	0.00272	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000184	0.00272	CcSEcCtD
Mifepristone—Myalgia—Prednisone—ankylosing spondylitis	0.000184	0.00271	CcSEcCtD
Mifepristone—Arthralgia—Prednisone—ankylosing spondylitis	0.000184	0.00271	CcSEcCtD
Mifepristone—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000184	0.00271	CcSEcCtD
Mifepristone—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000183	0.00271	CcSEcCtD
Mifepristone—Anxiety—Prednisone—ankylosing spondylitis	0.000183	0.0027	CcSEcCtD
Mifepristone—Insomnia—Dexamethasone—ankylosing spondylitis	0.000183	0.0027	CcSEcCtD
Mifepristone—Insomnia—Betamethasone—ankylosing spondylitis	0.000183	0.0027	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000182	0.00269	CcSEcCtD
Mifepristone—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000182	0.00268	CcSEcCtD
Mifepristone—Discomfort—Prednisone—ankylosing spondylitis	0.000181	0.00268	CcSEcCtD
Mifepristone—Mental disorder—Methotrexate—ankylosing spondylitis	0.000181	0.00268	CcSEcCtD
Mifepristone—Malnutrition—Methotrexate—ankylosing spondylitis	0.00018	0.00266	CcSEcCtD
Mifepristone—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000178	0.00264	CcSEcCtD
Mifepristone—Urticaria—Triamcinolone—ankylosing spondylitis	0.000177	0.00261	CcSEcCtD
Mifepristone—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000177	0.00261	CcSEcCtD
Mifepristone—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000176	0.0026	CcSEcCtD
Mifepristone—Oedema—Prednisone—ankylosing spondylitis	0.000176	0.0026	CcSEcCtD
Mifepristone—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000176	0.0026	CcSEcCtD
Mifepristone—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000176	0.0026	CcSEcCtD
Mifepristone—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000176	0.0026	CcSEcCtD
Mifepristone—Infection—Prednisone—ankylosing spondylitis	0.000175	0.00258	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000174	0.00258	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000174	0.00258	CcSEcCtD
Mifepristone—Back pain—Methotrexate—ankylosing spondylitis	0.000174	0.00258	CcSEcCtD
Mifepristone—Fatigue—Betamethasone—ankylosing spondylitis	0.000174	0.00257	CcSEcCtD
Mifepristone—Fatigue—Dexamethasone—ankylosing spondylitis	0.000174	0.00257	CcSEcCtD
Mifepristone—Pain—Betamethasone—ankylosing spondylitis	0.000173	0.00255	CcSEcCtD
Mifepristone—Pain—Dexamethasone—ankylosing spondylitis	0.000173	0.00255	CcSEcCtD
Mifepristone—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000173	0.00255	CcSEcCtD
Mifepristone—Skin disorder—Prednisone—ankylosing spondylitis	0.000171	0.00253	CcSEcCtD
Mifepristone—Anorexia—Prednisone—ankylosing spondylitis	0.000168	0.00248	CcSEcCtD
Mifepristone—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000167	0.00247	CcSEcCtD
Mifepristone—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000167	0.00246	CcSEcCtD
Mifepristone—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000167	0.00246	CcSEcCtD
Mifepristone—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000165	0.00244	CcSEcCtD
Mifepristone—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000165	0.00244	CcSEcCtD
Mifepristone—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000164	0.00242	CcSEcCtD
Mifepristone—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000164	0.00242	CcSEcCtD
Mifepristone—Malaise—Methotrexate—ankylosing spondylitis	0.000163	0.0024	CcSEcCtD
Mifepristone—Urticaria—Dexamethasone—ankylosing spondylitis	0.000161	0.00237	CcSEcCtD
Mifepristone—Urticaria—Betamethasone—ankylosing spondylitis	0.000161	0.00237	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00016	0.00237	CcSEcCtD
Mifepristone—Dizziness—Prednisolone—ankylosing spondylitis	0.00016	0.00237	CcSEcCtD
Mifepristone—Asthenia—Triamcinolone—ankylosing spondylitis	0.00016	0.00236	CcSEcCtD
Mifepristone—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00016	0.00236	CcSEcCtD
Mifepristone—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00016	0.00236	CcSEcCtD
Mifepristone—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00016	0.00236	CcSEcCtD
Mifepristone—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00016	0.00236	CcSEcCtD
Mifepristone—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000159	0.00236	CcSEcCtD
Mifepristone—Insomnia—Prednisone—ankylosing spondylitis	0.000159	0.00235	CcSEcCtD
Mifepristone—Pruritus—Triamcinolone—ankylosing spondylitis	0.000158	0.00233	CcSEcCtD
Mifepristone—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000157	0.00232	CcSEcCtD
Mifepristone—Myalgia—Methotrexate—ankylosing spondylitis	0.000153	0.00227	CcSEcCtD
Mifepristone—Arthralgia—Methotrexate—ankylosing spondylitis	0.000153	0.00227	CcSEcCtD
Mifepristone—Decreased appetite—Prednisone—ankylosing spondylitis	0.000153	0.00226	CcSEcCtD
Mifepristone—Rash—Prednisolone—ankylosing spondylitis	0.000153	0.00226	CcSEcCtD
Mifepristone—Dermatitis—Prednisolone—ankylosing spondylitis	0.000153	0.00225	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000152	0.00225	CcSEcCtD
Mifepristone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000152	0.00225	CcSEcCtD
Mifepristone—Fatigue—Prednisone—ankylosing spondylitis	0.000152	0.00224	CcSEcCtD
Mifepristone—Headache—Prednisolone—ankylosing spondylitis	0.000152	0.00224	CcSEcCtD
Mifepristone—Discomfort—Methotrexate—ankylosing spondylitis	0.000152	0.00224	CcSEcCtD
Mifepristone—Constipation—Prednisone—ankylosing spondylitis	0.000151	0.00222	CcSEcCtD
Mifepristone—Dizziness—Triamcinolone—ankylosing spondylitis	0.000147	0.00218	CcSEcCtD
Mifepristone—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000147	0.00217	CcSEcCtD
Mifepristone—Infection—Methotrexate—ankylosing spondylitis	0.000146	0.00216	CcSEcCtD
Mifepristone—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000145	0.00214	CcSEcCtD
Mifepristone—Asthenia—Dexamethasone—ankylosing spondylitis	0.000145	0.00214	CcSEcCtD
Mifepristone—Asthenia—Betamethasone—ankylosing spondylitis	0.000145	0.00214	CcSEcCtD
Mifepristone—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000144	0.00213	CcSEcCtD
Mifepristone—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000144	0.00213	CcSEcCtD
Mifepristone—Nausea—Prednisolone—ankylosing spondylitis	0.000144	0.00213	CcSEcCtD
Mifepristone—Pruritus—Dexamethasone—ankylosing spondylitis	0.000143	0.00211	CcSEcCtD
Mifepristone—Pruritus—Betamethasone—ankylosing spondylitis	0.000143	0.00211	CcSEcCtD
Mifepristone—Skin disorder—Methotrexate—ankylosing spondylitis	0.000143	0.00211	CcSEcCtD
Mifepristone—Vomiting—Triamcinolone—ankylosing spondylitis	0.000142	0.00209	CcSEcCtD
Mifepristone—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000141	0.00209	CcSEcCtD
Mifepristone—Rash—Triamcinolone—ankylosing spondylitis	0.00014	0.00207	CcSEcCtD
Mifepristone—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00014	0.00207	CcSEcCtD
Mifepristone—Anorexia—Methotrexate—ankylosing spondylitis	0.00014	0.00207	CcSEcCtD
Mifepristone—Rash—Methylprednisolone—ankylosing spondylitis	0.00014	0.00207	CcSEcCtD
Mifepristone—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00014	0.00207	CcSEcCtD
Mifepristone—Urticaria—Prednisone—ankylosing spondylitis	0.00014	0.00207	CcSEcCtD
Mifepristone—Headache—Triamcinolone—ankylosing spondylitis	0.00014	0.00206	CcSEcCtD
Mifepristone—Headache—Methylprednisolone—ankylosing spondylitis	0.000139	0.00206	CcSEcCtD
Mifepristone—Abdominal pain—Prednisone—ankylosing spondylitis	0.000139	0.00206	CcSEcCtD
Mifepristone—Body temperature increased—Prednisone—ankylosing spondylitis	0.000139	0.00206	CcSEcCtD
Mifepristone—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000138	0.00204	CcSEcCtD
Mifepristone—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000138	0.00204	CcSEcCtD
Mifepristone—Hypotension—Methotrexate—ankylosing spondylitis	0.000137	0.00203	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000134	0.00198	CcSEcCtD
Mifepristone—Dizziness—Dexamethasone—ankylosing spondylitis	0.000134	0.00197	CcSEcCtD
Mifepristone—Dizziness—Betamethasone—ankylosing spondylitis	0.000134	0.00197	CcSEcCtD
Mifepristone—Insomnia—Methotrexate—ankylosing spondylitis	0.000133	0.00197	CcSEcCtD
Mifepristone—Nausea—Triamcinolone—ankylosing spondylitis	0.000132	0.00195	CcSEcCtD
Mifepristone—Nausea—Methylprednisolone—ankylosing spondylitis	0.000132	0.00195	CcSEcCtD
Mifepristone—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000131	0.00194	CcSEcCtD
Mifepristone—Somnolence—Methotrexate—ankylosing spondylitis	0.000131	0.00193	CcSEcCtD
Mifepristone—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00013	0.00192	CcSEcCtD
Mifepristone—Vomiting—Betamethasone—ankylosing spondylitis	0.000128	0.0019	CcSEcCtD
Mifepristone—Vomiting—Dexamethasone—ankylosing spondylitis	0.000128	0.0019	CcSEcCtD
Mifepristone—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000128	0.00189	CcSEcCtD
Mifepristone—Rash—Betamethasone—ankylosing spondylitis	0.000127	0.00188	CcSEcCtD
Mifepristone—Rash—Dexamethasone—ankylosing spondylitis	0.000127	0.00188	CcSEcCtD
Mifepristone—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000127	0.00188	CcSEcCtD
Mifepristone—Dermatitis—Betamethasone—ankylosing spondylitis	0.000127	0.00188	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000127	0.00188	CcSEcCtD
Mifepristone—Fatigue—Methotrexate—ankylosing spondylitis	0.000127	0.00187	CcSEcCtD
Mifepristone—Headache—Betamethasone—ankylosing spondylitis	0.000127	0.00187	CcSEcCtD
Mifepristone—Headache—Dexamethasone—ankylosing spondylitis	0.000127	0.00187	CcSEcCtD
Mifepristone—Asthenia—Prednisone—ankylosing spondylitis	0.000126	0.00187	CcSEcCtD
Mifepristone—Pain—Methotrexate—ankylosing spondylitis	0.000126	0.00186	CcSEcCtD
Mifepristone—Pruritus—Prednisone—ankylosing spondylitis	0.000125	0.00184	CcSEcCtD
Mifepristone—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000121	0.00179	CcSEcCtD
Mifepristone—Diarrhoea—Prednisone—ankylosing spondylitis	0.00012	0.00178	CcSEcCtD
Mifepristone—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00012	0.00178	CcSEcCtD
Mifepristone—Nausea—Dexamethasone—ankylosing spondylitis	0.00012	0.00177	CcSEcCtD
Mifepristone—Nausea—Betamethasone—ankylosing spondylitis	0.00012	0.00177	CcSEcCtD
Mifepristone—Urticaria—Methotrexate—ankylosing spondylitis	0.000117	0.00173	CcSEcCtD
Mifepristone—Dizziness—Prednisone—ankylosing spondylitis	0.000116	0.00172	CcSEcCtD
Mifepristone—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000116	0.00172	CcSEcCtD
Mifepristone—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000116	0.00172	CcSEcCtD
Mifepristone—Vomiting—Prednisone—ankylosing spondylitis	0.000112	0.00165	CcSEcCtD
Mifepristone—Rash—Prednisone—ankylosing spondylitis	0.000111	0.00164	CcSEcCtD
Mifepristone—Dermatitis—Prednisone—ankylosing spondylitis	0.000111	0.00164	CcSEcCtD
Mifepristone—Headache—Prednisone—ankylosing spondylitis	0.00011	0.00163	CcSEcCtD
Mifepristone—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000108	0.0016	CcSEcCtD
Mifepristone—Asthenia—Methotrexate—ankylosing spondylitis	0.000106	0.00156	CcSEcCtD
Mifepristone—Nausea—Prednisone—ankylosing spondylitis	0.000105	0.00154	CcSEcCtD
Mifepristone—Pruritus—Methotrexate—ankylosing spondylitis	0.000104	0.00154	CcSEcCtD
Mifepristone—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000101	0.00149	CcSEcCtD
Mifepristone—Dizziness—Methotrexate—ankylosing spondylitis	9.73e-05	0.00144	CcSEcCtD
Mifepristone—Vomiting—Methotrexate—ankylosing spondylitis	9.35e-05	0.00138	CcSEcCtD
Mifepristone—Rash—Methotrexate—ankylosing spondylitis	9.27e-05	0.00137	CcSEcCtD
Mifepristone—Dermatitis—Methotrexate—ankylosing spondylitis	9.27e-05	0.00137	CcSEcCtD
Mifepristone—Headache—Methotrexate—ankylosing spondylitis	9.21e-05	0.00136	CcSEcCtD
Mifepristone—Nausea—Methotrexate—ankylosing spondylitis	8.74e-05	0.00129	CcSEcCtD
